Category Archives: Advocacy and Regulations

Bill Proposing an Appropriation into the Arizona Health Innovation Trust Fund Receives Unanimous Support in the Senate Health and Human Services Committee

Posted on by

SB1019: appropriation; health innovation trust fund received its first hearing in Arizona’s Senate Health and Human Services Committee on January 16, 2024.  As currently written, SB1019 appropriates $5M to the Arizona Health Innovation Trust Fund, and declares that it is the Legislature’s intent that the Fund, consisting of monies appropriated by the Legislature, gifts or grants donated or given to the Fund and earnings from the Fund, steadily grow to ultimately maintain a permanent endowment balance of at least $200 million. 

SB1019 received a unanimous do pass recommendation.  It now is eligible for consideration by the Senate Appropriations Committee.Continue reading→

An Interview with AZBio President and CEO on Life Sciences M&A in Arizona

Posted on by

Recently, PULSE had a conversation with Joan Koerber-Walker, president and CEO of AZBio, which recently celebrated 20 years of supporting the growth of Arizona’s life science industry. Joan, who has led AZBio since 2011, has a vested interest in making Arizona a place where bioscience organizations can thrive and find success, while supporting economic growth at the local and state level. PULSE asked Joan for her perspective on how mergers and acquisitions (M&A) have impacted and benefited Arizona’s economic outlook and contributions to the state.

Continue reading→

Patients will lose access to 40% of future medicines because of the IRA, new research finds.

Posted on by

New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas. The effects of the IRA will have a far more serious impact on the development of new medicines than has been reported, according to the research.Continue reading→

KOL Conversation: The Impact of the IRA on Oncology Patient Care

Posted on by

Impact of the IRA on Oncology Patient Care features an interview with Dr. Barbara L. McAneny, MD, FASCO, MACP Former President for the American Medical Association and the New Mexico Medical Society (NMMS); and currently CEO, New Mexico Cancer Center.

With Dr. Steve Potts CEO, Anticipate Bioscience.

Impact of the IRA on Oncology Patient Care was recorded on the 26th of May 2023Continue reading→